Red Abbey is a US-based venture investment platform focused primarily on life sciences and healthcare-related companies, including biotechnology, medical devices, diagnostics, and specialty pharmaceuticals. The firm invests in early- and later-stage private companies, often supporting the development of novel therapeutics, research tools, and medical technologies aimed at addressing significant disease areas. It typically targets companies with strong scientific foundations and experienced management teams, combining capital deployment with deep sector expertise and due diligence capabilities. Red Abbey operates with a long-term, research-driven investment philosophy and has historically participated in both privately held and publicly traded life sciences companies, as well as PIPE transactions. The organization is structured around a small, specialist investment team with strong networks across scientific, clinical, and financial ecosystems.